Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Novel Type 2 Diabetes Mellitus Preventive Therapies [Phase 1]
A Phase 1 clinical trial at Boston Medical Center evaluating novel preventive therapies for Type 2 diabetes mellitus has completed its Phase…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of alogliptin in children, adolescents, and adults with Type 2 d…
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Sardine Diet Intervention Study to Assess Benefits to the Metabolic Profile in Type 2 Diabetes Mellitus Patients [NA]
A completed clinical trial evaluating whether a sardine-based diet improves metabolic profile in patients with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin [Phase 2, Phase 3]
Clinical trial update reporting results from a Phase 2/Phase 3 study comparing LY2189265 to sitagliptin in adults with Type 2 diabetes melli…
-
CLINICAL_TRIALS research · 2015-01-28Clinical Trial Update: The Effect of Shear- Force at the Skin in Patients With Diabetes Mellitus [NA]
This clinical trial update describes a study on the effect of shear forces at the skin in patients with diabetes mellitus, including pressur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254) [Phase 3]
Phase 3 study assessing adding sitagliptin to stable insulin therapy (with or without metformin) in Type 2 diabetes; completed with results …
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
This clinical trial update characterizes the variability of insulin secretory parameters during Meal Tolerance Tests and maximal stimulation…
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus [NA]
A clinical trial evaluates the impact of laparoscopic Roux-en-Y gastric bypass on individuals with non-severe obesity and type 2 diabetes me…
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients [NA]
Clinical trial exploring whether exenatide can improve heart function in patients with type 2 diabetes mellitus and heart failure; the statu…
-
FDA approval · 2015-01-26FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly, including the associated diluent as part of the approved product.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial in participants with type 2 diabetes mellitus completed; results posted in 2015.
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes [Phase 3]
This is a Phase 3 clinical trial evaluating whether pantoprazole affects glycemic control and post-prandial glucose in adults with Type 2 di…
-
FDA approval · 2015-01-23FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk, expanding the product’s regulatory authorization…
-
FDA approval · 2015-01-23FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in changes to the product labeling as…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Diabetes Visual Function Supplement Study [NA]
The Diabetes Visual Function Supplement Study sponsored by ZeaVision has completed, evaluating its effects in individuals with Type 1 or Typ…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Health2010-14: Monitoring Biomarkers of Chronic Diseases in the General Population
The Health2010-14 study monitoring biomarkers in the general population has completed, covering chronic diseases including cardiovascular di…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AndroGel in men with hypogonadism and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients [Phase 3]
A Phase 3 trial comparing the metformin/glimepiride combination against metformin alone and glimepiride alone in newly diagnosed type 2 diab…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh
A completed cross-sectional survey sponsored by Novo Nordisk evaluates diabetes management, control, complications, and psychosocial aspects…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) [Phase 1]
Phase 1 trial comparing four weeks of linagliptin versus glimepiride and placebo in adults with type 2 diabetes, assessing endothelial funct…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) [Phase 3]
A completed Phase 3 trial (AWARD-2) in participants with Type 2 diabetes mellitus has posted results.
-
FDA approval · 2015-01-16FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Glyburide from Teva Pharmaceuticals USA, Inc., updating an existing glyburide product under …
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) [Phase 3]
This update reports the completion of the Phase 3 AWARD-3 trial in adults with type 2 diabetes and that results have been posted.
-
FDA approval · 2015-01-14FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. This action represents a supplemental approval, li…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus [Phase 1]
Phase 1 multiple-dose study of PF-05231023 in adults with poor lipid control, with and without Type 2 diabetes mellitus; the trial is comple…